This week, 7 Pharmaceuticals stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Taro Pharmaceutical Industries Ltd.’s (TARO) ratings are looking better this week, moving up to a B from last week’s C. Taro Pharmaceutical Industries Ltd. is engaged in developing, manufacturing, and marketing prescription and over-the-counter pharmaceutical products, as well as active pharmaceutical ingredients in the United States, Canada and Israel. The company also gets A’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of TARO stock.
The rating of Eli Lilly and Company (LLY) moves up this week, rising from a C to a B. Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The company also gets A’s in earnings momentum and return on equity. For more information, get Portfolio Grader’s complete analysis of LLY stock.
Bristol-Myers Squibb Company (BMY) earns a B this week, jumping up from last week’s grade of C. Bristol-Myers Squibb Company is a global company that develops, produces and sells pharmaceutical products. The company also gets A’s in earnings revisions and earnings surprise. For more information, get Portfolio Grader’s complete analysis of BMY stock.
Heska Corporation (HSKA) boosts its rating from a B to a A this week. Heska Corporation discovers, develops, manufactures, and markets companion animal health products, primarily for dogs, cats, and horses. The company also gets A’s in sales growth, earnings growth, and earnings surprise. For more information, get Portfolio Grader’s complete analysis of HSKA stock.
This week, Theravance Biopharma Inc’s (TBPH) ratings are up from a C last week to a B. The company also gets A’s in sales growth and earnings revisions. For more information, get Portfolio Grader’s complete analysis of TBPH stock.
SciClone Pharmaceuticals, Inc. (SCLN) improves from a B to a A rating this week. SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs. The company also gets A’s in sales growth, earnings growth, earnings momentum, and return on equity. For more information, get Portfolio Grader’s complete analysis of SCLN stock.
Adamis Pharmaceuticals Corporation (ADMP) is seeing ratings go up from a B last week to a A this week. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of ADMP stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
